Literature DB >> 2966886

Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudate-putamen.

V L Dawson1, T M Dawson, F M Filloux, J K Wamsley.   

Abstract

The aziridinium ion of ethylcholine (AF64A) is a neurotoxin that has demonstrated selectivity for cholinergic neurons. Unilateral stereotaxic injection of AF64A into the caudate-putamen of rats, resulted in a decrease in dopamine D-2 receptors as evidenced by a decrease in [3H]-sulpiride binding. Dopamine D-1 receptors, labeled with [3H]-SCH 23390, were unchanged. The efficacy of the lesion was demonstrated by the reduction of Na+-dependent high affinity choline uptake sites labeled with [3H]-hemicholinium-3. These data indicate that a population of D-2 receptors are postsynaptic on cholinergic interneurons within the striatum of rat brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966886     DOI: 10.1016/0024-3205(88)90492-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

Review 1.  Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior.

Authors:  Eduardo F Gallo
Journal:  Neurochem Int       Date:  2019-02-01       Impact factor: 3.921

2.  Gnal haploinsufficiency causes genomic instability and increased sensitivity to haloperidol.

Authors:  Mohammad Moshahid Khan; Jianfeng Xiao; T J Hollingsworth; Damini Patel; Dana E Selley; Trevor L Ring; Mark S LeDoux
Journal:  Exp Neurol       Date:  2019-04-26       Impact factor: 5.330

3.  Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling.

Authors:  Henry H Yin; David M Lovinger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-12       Impact factor: 11.205

Review 4.  The calretinin interneurons of the striatum: comparisons between rodents and primates under normal and pathological conditions.

Authors:  S Petryszyn; A Parent; Martin Parent
Journal:  J Neural Transm (Vienna)       Date:  2017-02-06       Impact factor: 3.575

5.  Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus).

Authors:  J Staedt; G Stoppe; A Kögler; D Munz; H Riemann; D Emrich; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1993

6.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

7.  Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).

Authors:  J Staedt; G Stoppe; A Kögler; H Riemann; G Hajak; D L Munz; D Emrich; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1995

8.  Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene.

Authors:  C Le Moine; E Normand; B Bloch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 9.  Dopamine D2 receptors and striatopallidal transmission in addiction and obesity.

Authors:  Paul J Kenny; George Voren; Paul M Johnson
Journal:  Curr Opin Neurobiol       Date:  2013-05-29       Impact factor: 6.627

Review 10.  Striatal cholinergic interneurons and Parkinson's disease.

Authors:  Asami Tanimura; Tristano Pancani; Sean Austin O Lim; Cecilia Tubert; Alexandra E Melendez; Weixing Shen; Dalton James Surmeier
Journal:  Eur J Neurosci       Date:  2017-07-20       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.